HCR WEALTH ADVISORS – Eli Lilly and Company Transaction History
HCR WEALTH ADVISORS portfolio value:
$384,000
portfolio value
HCR WEALTH ADVISORS quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.64% | 74 shares | 23K | $323.35 | 1.18K |
| Q2 2022 | share | 0.00% | 0 shares | 42K | $324.23 | 1.11K | |
| Q1 2022 | share | 0.00% | 0 shares | 11K | $286.37 | 1.11K | |
| Q4 2021 | share | 0.00% | 0 shares | 51K | $277.25 | 1.11K | |
| Q3 2021 | share | Decrease | -3.72% | -43 shares | -9K | $230.3 | 1.11K |
| Q2 2021 | share | Increase | +2.94% | 33 shares | 56K | $228.04 | 1.15K |
| Q1 2021 | share | Decrease | -19.43% | -271 shares | -26K | $184.81 | 1.12K |
| Q4 2020 | share | Increase | 0.00% | 1.39K shares | 236K | $166.32 | 1.39K |
| Q3 2020 | share | Decrease | -100.00% | -1.32K shares | -217K | $145.05 | 0 |
| Q2 2020 | share | Increase | 0.00% | 1.32K shares | 217K | $160.1 | 1.32K |